Hua Medicine Announces that the Pharmaceutical Service of Hong Kong Department of Health of China has Officially Accepted the Application for Marketing Authorization of the New Drug Dorzagliatin
Hua Medicine Announces that the Pharmaceutical Service of Hong Kong Department of Health of China has Officially Accepted the Application for Marketing Authorization of the New Drug Dorzagliatin
Hua Medicine Announces 2025 Interim Results
Hua Medicine Announces 2025 Interim Results
Hua Medicine Announces at 2025 ADA Scientific Sessions that Dorzagliatin Combined with DPP-4 Inhibitor Shows Promise in Reducing Blood Lipids While Restoring Glucose Homeostasis
Hua Medicine Announces at 2025 ADA Scientific Sessions that Dorzagliatin Combined with DPP-4 Inhibitor Shows Promise in Reducing Blood Lipids While Restoring Glucose Homeostasis
Hua Medicine Announces 2024 Annual Results
Hua Medicine Announces 2024 Annual Results
Dr. Li Chen Honored as A Leading Figure in Shanghai's Industry and Commerce
Dr. Li Chen Honored as A Leading Figure in Shanghai's Industry and Commerce
Hua Medicine Awarded Shanghai Innovative Enterprise Headquarters
Hua Medicine Awarded Shanghai Innovative Enterprise Headquarters
Founder of Hua Medicine Dr. Chen Li was awarded the 'C.C. Tan Life Science Industrialization Award'
Founder of Hua Medicine Dr. Chen Li was awarded the 'C.C. Tan Life Science Industrialization Award'